Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Effects of cerebrovascular disease on amyloid precursor protein metabolites in cerebrospinal fluid.

Selnes P, Blennow K, Zetterberg H, Grambaite R, Rosengren L, Johnsen L, Stenset V, Fladby T.

Cerebrospinal Fluid Res. 2010 Jul 30;7:10. doi: 10.1186/1743-8454-7-10.

2.

Amyloid-β metabolism in Niemann-Pick C disease models and patients.

Mattsson N, Olsson M, Gustavsson MK, Kosicek M, Malnar M, Månsson JE, Blomqvist M, Gobom J, Andreasson U, Brinkmalm G, Vite C, Hecimovic S, Hastings C, Blennow K, Zetterberg H, Portelius E.

Metab Brain Dis. 2012 Dec;27(4):573-85. doi: 10.1007/s11011-012-9332-8. Epub 2012 Sep 1.

PMID:
22935999
3.

Cerebrospinal fluid biomarkers of β-amyloid metabolism and neuronal damage in epileptic seizures.

Shahim P, Rejdak R, Ksiazek P, Blennow K, Zetterberg H, Mattsson N, Rejdak K.

Eur J Neurol. 2014 Mar;21(3):486-91. doi: 10.1111/ene.12336. Epub 2013 Dec 26.

PMID:
24372994
4.

Measurement of alpha- and beta-secretase cleaved amyloid precursor protein in cerebrospinal fluid from Alzheimer patients.

Olsson A, Höglund K, Sjögren M, Andreasen N, Minthon L, Lannfelt L, Buerger K, Möller HJ, Hampel H, Davidsson P, Blennow K.

Exp Neurol. 2003 Sep;183(1):74-80.

PMID:
12957490
5.

Soluble amyloid precursor proteins in the cerebrospinal fluid as novel potential biomarkers of Alzheimer's disease: a multicenter study.

Lewczuk P, Kamrowski-Kruck H, Peters O, Heuser I, Jessen F, Popp J, Bürger K, Hampel H, Frölich L, Wolf S, Prinz B, Jahn H, Luckhaus Ch, Perneczky R, Hüll M, Schröder J, Kessler H, Pantel J, Gertz HJ, Klafki HW, Kölsch H, Reulbach U, Esselmann H, Maler JM, Bibl M, Kornhuber J, Wiltfang J.

Mol Psychiatry. 2010 Feb;15(2):138-45. doi: 10.1038/mp.2008.84. Epub 2008 Jul 29.

PMID:
18663368
6.

Levels of alpha- and beta-secretase cleaved amyloid precursor protein in the cerebrospinal fluid of Alzheimer's disease patients.

Sennvik K, Fastbom J, Blomberg M, Wahlund LO, Winblad B, Benedikz E.

Neurosci Lett. 2000 Jan 14;278(3):169-72.

PMID:
10653020
7.

Nicotine reduces the secretion of Alzheimer's beta-amyloid precursor protein containing beta-amyloid peptide in the rat without altering synaptic proteins.

Lahiri DK, Utsuki T, Chen D, Farlow MR, Shoaib M, Ingram DK, Greig NH.

Ann N Y Acad Sci. 2002 Jun;965:364-72.

PMID:
12105112
8.

Open-heart surgery increases cerebrospinal fluid levels of Alzheimer-associated amyloid β.

Reinsfelt B, Westerlind A, Blennow K, Zetterberg H, Ricksten SE.

Acta Anaesthesiol Scand. 2013 Jan;57(1):82-8. doi: 10.1111/j.1399-6576.2012.02769.x. Epub 2012 Sep 24. Erratum in: Acta Anaesthesiol Scand. 2013 Nov;57(10):1333.

PMID:
22998015
9.

Neuroinflammation in Lyme neuroborreliosis affects amyloid metabolism.

Mattsson N, Bremell D, Anckarsäter R, Blennow K, Anckarsäter H, Zetterberg H, Hagberg L.

BMC Neurol. 2010 Jun 22;10:51. doi: 10.1186/1471-2377-10-51.

10.

Exploring Alzheimer molecular pathology in Down's syndrome cerebrospinal fluid.

Portelius E, Soininen H, Andreasson U, Zetterberg H, Persson R, Karlsson G, Blennow K, Herukka SK, Mattsson N.

Neurodegener Dis. 2014;14(2):98-106. doi: 10.1159/000358800. Epub 2014 Jun 27.

PMID:
24992945
11.
12.

Cerebrospinal fluid biomarkers of β-amyloid metabolism in multiple sclerosis.

Augutis K, Axelsson M, Portelius E, Brinkmalm G, Andreasson U, Gustavsson MK, Malmeström C, Lycke J, Blennow K, Zetterberg H, Mattsson N.

Mult Scler. 2013 Apr;19(5):543-52. doi: 10.1177/1352458512460603. Epub 2012 Oct 15.

PMID:
23069872
13.

Cerebral white matter lesions - associations with Aβ isoforms and amyloid PET.

van Westen D, Lindqvist D, Blennow K, Minthon L, Nägga K, Stomrud E, Zetterberg H, Hansson O.

Sci Rep. 2016 Feb 9;6:20709. doi: 10.1038/srep20709.

14.

Toward a reliable distinction between patients with mild cognitive impairment and Alzheimer-type dementia versus major depression.

Post A, Ackl N, Rücker M, Schreiber Y, Binder EB, Ising M, Sonntag A, Holsboer F, Almeida OF.

Biol Psychiatry. 2006 May 1;59(9):858-62. Epub 2005 Dec 1.

PMID:
16325150
15.

Biochemical studies in Normal Pressure Hydrocephalus (NPH) patients: change in CSF levels of amyloid precursor protein (APP), amyloid-beta (Aβ) peptide and phospho-tau.

Ray B, Reyes PF, Lahiri DK.

J Psychiatr Res. 2011 Apr;45(4):539-47. doi: 10.1016/j.jpsychires.2010.07.011. Epub 2010 Sep 9.

16.

Plasma and cerebrospinal fluid amyloid beta for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).

Ritchie C, Smailagic N, Noel-Storr AH, Takwoingi Y, Flicker L, Mason SE, McShane R.

Cochrane Database Syst Rev. 2014 Jun 10;(6):CD008782. doi: 10.1002/14651858.CD008782.pub4. Review.

PMID:
24913723
17.

BACE1 gene variants do not influence BACE1 activity, levels of APP or Aβ isoforms in CSF in Alzheimer's disease.

Sjölander A, Zetterberg H, Andreasson U, Minthon L, Blennow K.

Mol Neurodegener. 2010 Sep 17;5:37. doi: 10.1186/1750-1326-5-37.

18.

Cholinesterase inhibitors, beta-amyloid precursor protein and amyloid beta-peptides in Alzheimer's disease.

Lahiri DK, Farlow MR, Hintz N, Utsuki T, Greig NH.

Acta Neurol Scand Suppl. 2000;176:60-7.

PMID:
11273593
19.

Parietal white matter lesions in Alzheimer's disease are associated with cortical neurodegenerative pathology, but not with small vessel disease.

McAleese KE, Walker L, Graham S, Moya ELJ, Johnson M, Erskine D, Colloby SJ, Dey M, Martin-Ruiz C, Taylor JP, Thomas AJ, McKeith IG, De Carli C, Attems J.

Acta Neuropathol. 2017 Jun 21. doi: 10.1007/s00401-017-1738-2. [Epub ahead of print]

PMID:
28638989
20.

Soluble amyloid precursor protein-α modulates β-secretase activity and amyloid-β generation.

Obregon D, Hou H, Deng J, Giunta B, Tian J, Darlington D, Shahaduzzaman M, Zhu Y, Mori T, Mattson MP, Tan J.

Nat Commun. 2012 Apr 10;3:777. doi: 10.1038/ncomms1781.

Supplemental Content

Support Center